Drs Milowsky and Smith discuss the evolving use of checkpoint inhibition in patients with advanced bladder cancer.
This activity is intended for oncologists, urologists, nurses, and other healthcare professionals who treat patients with bladder cancer.
The goal of this activity is to discuss the most up-to-date use of immunotherapy in the treatment of patients with advanced bladder cancer.
Approximate Time to Complete: 30 minutes
Credit Available: Sep. 27, 2018- Sep. 27, 2019
Developed through a partnership between SITC and Medscape.
Upon completion of this activity, participants will be able to:
- Have increased knowledge regarding the individual roles of multidisciplinary medical cancer care team members in the treatment of patients with advanced bladder cancer
- Have greater competence related to appropriate use of cancer immunotherapies across the continuum of care for patients with advanced bladder cancer